Expert advisers to the Centers for Disease Control and Prevention will meet on Thursday to discuss what federal health officials see as a concerning increase in the rates of a rare but serious blood clotting disorder linked to Johnson & Johnson’s coronavirus vaccine.The Advisory Committee on Immunization Practices will see new data at the meeting…
